Partial nephrectomy in the setting of metastatic renal cell carcinoma.

about

Outlining the limits of partial nephrectomy.

P2860

Q38559573-D0AE28F6-79DB-472F-AFEC-DED101AB6FC6

P2860

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q35852568

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

@ast

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

@en

type

Item

label

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

@ast

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

@en

prefLabel

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

@ast

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

@en

P1476

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

@en

P2093

Christopher G Wood

http://www.w3.org/2001/XMLSchema#string

Eric Jonasch

http://www.w3.org/2001/XMLSchema#string

Jose A Karam

http://www.w3.org/2001/XMLSchema#string

Kara N Babaian

http://www.w3.org/2001/XMLSchema#string

Megan M Merrill

http://www.w3.org/2001/XMLSchema#string

Nizar M Tannir

http://www.w3.org/2001/XMLSchema#string

Pheroze Tamboli

http://www.w3.org/2001/XMLSchema#string

Surena Matin

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

Renal-cell carcinoma.

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases.

Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.

The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.

P304

36-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2014.01.086

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

192

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24518767

http://www.w3.org/2001/XMLSchema#string

P932

4502598

http://www.w3.org/2001/XMLSchema#string

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

about

P2860

P2860

Partial nephrectomy in the setting of metastatic renal cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932